Iguratimod

Information about Iguratimod

Iguratimod uses

Iguratimod is used in the treatment of rheumatoid arthritis.

How iguratimod works

Iguratimod is a disease-modifying anti-rheumatic drug (DMARD). It works by improving abnormal immunological response and suppressing the production of substances that cause inflammation (redness and swelling) in rheumatoid arthritis.

Common side effects of iguratimod

Diarrhea, Nausea, Rash, Abdominal pain, Vomiting, Stomatitis (Inflammation of the mouth), Photosensitivity, Decreased appetite, Itching, Hives, Nasopharyngitis (inflammation of the throat and nasal passages), Increased aspartate aminotransferase, Increased alanine aminotransferase, Aplastic anemia, Shortness of breath, Nosebleeds, Bleeding gums, Agranulocytosis (deficiency of granulocytes in the blood), Decreased white blood cell count (lymphocytes), Interstitial pneumonia

Available Medicine for Iguratimod

  • ₹285
    Ipca Laboratories Ltd
    1 variant(s)
  • ₹299
    Zydus Cadila
    1 variant(s)
  • ₹329
    Dr Reddy's Laboratories Ltd
    1 variant(s)
  • ₹280
    Hetero Drugs Ltd
    1 variant(s)
  • ₹270
    Overseas Healthcare Pvt Ltd
    1 variant(s)
  • ₹258 to ₹427
    Ajanta Pharma Ltd
    2 variant(s)
  • ₹235
    Medley Pharmaceuticals
    1 variant(s)
  • ₹239
    Goldenlad Pharmaceutical Pvt Ltd
    1 variant(s)
  • ₹273
    Solarium Pharmaceuticals
    1 variant(s)

Content on this page was last updated on 16 November, 2023, by Dr. Varun Gupta (MD Pharmacology)